Showing results (341-350 of 404) with videos related to
Sort By:
Pageof 41
Medical Oncology (Northwood, London, England)|April 2, 2017
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumabIcro Meattini, Giuseppe Curigliano, Francesca Terziani, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 6, 2013
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II studyStefano Cascinu, Rossana Berardi, Alberto Sobrero, et al.Journal of Clinical Medicine|April 8, 2020
Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter StudyArturo Cuomo, Marco Cascella, Cira Antonietta Forte, et al.Oncotarget|September 24, 2015
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenibLuca Faloppi, Maristella Bianconi, Riccardo Giampieri, et al.Tumori|July 6, 2018
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agendaTiziana Magnani, Sergio Bracarda, Rolando M D'Angelillo, et al.Lung Cancer (Amsterdam, Netherlands)|May 20, 2011
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) studyCesare Gridelli, Andrea Ardizzoni, Sandro Barni, et al.JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.Tumori|February 11, 2012
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic reviewMario Airoldi, Dino Amadori, Sandro Barni, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patientsCesare Gridelli, Silvia Novello, Nicoletta Zilembo, et al.Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.Pageof 41